Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 42, 2013 - Issue 7
407
Views
7
CrossRef citations to date
0
Altmetric
Thematic Articles

The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells

Pages 510-518 | Published online: 05 Sep 2013

References

  • Aki Y, Kondo A, Nakamura H, Togari A. (2008). Lysophosphatidic acid-stimulated interleukin-6 and −8 synthesis through LPA1 receptors on human osteoblasts. Arch Oral Biol, 53, 207–13
  • Blackburn J, Mansell JP. (2012). The emerging role of lysophosphatidic acid (LPA) in skeletal biology. Bone, 50, 756–62
  • Carpio LC, Stephan E, Kamer A, Dziak R. (1999). Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells. Prostaglandins, Leukotrienes Essential Fatty Acids, 61, 267–73
  • David M, Wannecq E, Descotes F, et al. (2010). Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts. PLoS One, 5, e9741
  • De AK, Kodys KM, Yeh HBS, Miller-Graziano C. (2000). Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein (Hsp-27_ suggests Hsp27 is primarily an anti-inflammatory stimulus. J Immunol, 165, 3951--8
  • Dorsam G, Graeler MH, Seroogy, C, et al. (2003). Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J Immunol, 171, 3500–7
  • Dziak R, Yang BM, Leung BW, et al. (2003). Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. Prostaglandins, Leukotrienes Essential Fatty Acids, 68, 239–49
  • Gardell SE, Dubin AE, Chun J. (2006). Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med, 12, 65–75
  • Graler MH, Goetzl EJ. (2004). The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB, 18, 551–3
  • Hla T, Lee MJ. Ancellin N, et al. (1999). Sphingosine-1-phosphate extracellular mediator or intracellular second messenger? Biochem Pharmacol, 58, 201–7
  • Ishii I, Fukushima N, Ye X, Chun J. (2004). Lysophospholipid receptors: signaling and biology. Annu Rev Biochem, 73, 321–54
  • Ishii M, Egen JG, Klauschen F, et al. (2009). Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature, 458, 524--8
  • Ishii M, Kikuta J, Shimazu Y, et al. (2010). Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. JEM, 207, 2793--8
  • Jolly PS, Bektas M, Olivera A, et al. (2004). Transactivation of sphingosine-1- phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med, 199, 959–70
  • Kikuta J, Ishii M. (2013). Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. Rheumatology, 52, 226–34
  • Kikuta J, Iwai K, Saeki Y, Ishii M. (2011). S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. Rheumatol Int, 31, 967–9
  • Koizumi K, Saitoh Y, Minami T, et al. (2009). Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption. J Immunol, 2183, 7825–31
  • Kozawa O, Niwa M, Matsumo H, et al. (1999). Sphingosine 1-phosphate induces heat shock protein 27 via p38 mitogen-activated protein kinase ctivation in osteoblasts. J Bone Miner Res, 14, 1761–7
  • Kunisawa J, Gohda M, Kurashuma Y. (2008). Sphingosine 1- phosphate-dependent trafficking of peritoneal B cells requires functional inducing kinase in stromal cells. Blood, 111, 4646–52
  • Lapierre DM, Tanabe NA, Spencer M, et al. (2010). Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival. J Biol Chem, 285, 25792–801
  • Lee MJ, Evans M, Hla T. (1996). The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway. J Biol Chem, 271, 11272–79
  • Liu Y-B, Kharode Y, Bodine PVN, et al. (2010). LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4. J Cell Biochem, 109, 794–800
  • Matloubian M, Lo CG, Cinamon, G, et al. (2004). Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 427, 355–60
  • Panupinthu N, Rogers JT, Zhao L, et al. (2008). P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signalling axis promoting osteogenesis. J Cell Biol, 181, 859–71
  • Panupinthu N, Zhao L, Possmayer F, et al. (2007). P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem, 282, 3403–12
  • Pappu R, Schwab SR, Cornelissen I, et al. (2007). Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science, 316, 295–8
  • Pitman MR, Woodcock JM, Lopez AF & Pitson SM. (2012). Molecular targets of FTY720 (fingolimod). Curr Mol Med, 12, 1207–19
  • Rivera J, Proia RL, Olivera L. (2008). The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol, 8, 753–63
  • Sanchez T, Hla T. (2004). Structural and functional characteristics of S1P receptors. J Cell Biochem, 92, 913–22
  • Spiegel S, Merrill AH Jr. (1996). Sphingolipid metabolism and cell growth regulation. FASEB J, 10, 1388–97
  • Sugiyama T, Kohara H, Noda M, Nagasawa T. (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 2, 977–88
  • Van Brocklyn JR, Lee MJ, Menzeleev R, et al. (1998). Dual actions of sphingosine-1-phosphate extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol, 142, 229–40
  • Venkataraman K, Lee YM, Michaud J, et al. (2008). Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res, 102, 669–76
  • Wang F, Nohara K, Olivera A, et al. (1999). Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1 phosphate. Exper Cell Res, 247, 17–28
  • Waters KM, Jacobs JM, Gritsenkov MA, Karin NJ. (2011). Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth. Bone, 48, 1328–35
  • Waters KM, Tan R, Genetos DC, et al. (2007). DNA microarray analysis reveals a role for lysophosphatidic acid in the regulation of anti-inflammatory genes in MC3T3-E1 cells. Bone, 41, 833–41
  • Yokoo E, Yatomi Y, Takafuta T, et al. (2004). Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells. J Biochem, 135, 673–81
  • Yu X, Huang Y, Collin-Osdoby P, Osdoby P. (2003). Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res, 18, 1404–18
  • Zhang Q, Checovich WJ, Peters DM, et al. (1994). Modulation of cell surface fibronectin assembly sites by lysophosphatidic acid. J Cell Biol, 127, 1447–59
  • Zhang Q, Magnusson MK, Mosher DF. (1997). Lysophosphatidic acid and microtubule destabilizing agents stimulate fibronectin matrix assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol Biol Cell, 18, 1415–25
  • Zhang Q, Peyruchaud Q, French KJ, et al. (1999). Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood, 93, 2984–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.